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Summary 
The aim of the session was to discuss the current definitions of and criteria for hand osteoarthritis (OA) and to review the tools proposed for 
the clinical assessment of hand OA in research and trials. 
The American College of Rheumatology criteria for the classification and reporting of hand OA were discussed and their limitations noted; 
specifically, they are designed for symptomatic OA and based on physical examination. 
The differences between erosive and non-erosive hand OA were discussed as was the relationship between hand OA and generalized OA, 
since hand OA represents a generalized OA of hand joints and can be considered as a marker for developing eneralized OA (i.e. OA at other 
sites). 
Different clinical tools to assess patients were presented and discussed, such as pain assessment, Dreiser's functional index or Bellamy's 
AUSCAN for function assessment, assessment of the mobility, stiffness, inflammation and aesthetic damages. 
The agreements, disagreements and further studies to be performed to answer questions still debated are presented. 
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Dr Eric Vignon gave the introduction and set the objectives 
for the session. 
What is the definition of hand osteoarthritis 
(OA)? 
The definition largely varies according to different investi- 
gators, and depends on whether physical examination or 
radiography is used. Presently, the American College of 
Rheumatology (ACR) criteria for the classification of hand 
OA is the most frequently used definition for clinical studies. 
The ACR criteria are designed for symptomatic hand osteo- 
arthritis (OA) and are based on physical examination of 
patients with hand pain. 1 Sensitivity and specificity by 
classification tree are excellent (92 and 98%, respectively), 
and very good-to-excellent using a traditional format (94 
and 87%, respectively). 
Limitations of the ACR criteria for epidemiological 
studies have been mentioned in the paper by Hart (see this 
issue) and include (1) the duration of symptoms (most days 
for at least 1 month), (2) inclusion of patients with erosive 
OA, (3) lack of distinction of hand OA subsets, (4) exclusion 
of patients with OA involving the metacarpophalangeal 
joints, and (5) exclusion of patients with asymptomatic 
structural OA. 
Differences between nodal and erosive OA were 
discussed. Erosive OA is a radiographic subset of OA 
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involving the distal and proximal interphalangeal joints, 
accompanied by inflammatory symptoms and signs. 
Radiographic features include central erosions and col- 
lapse of subchondral bone with interosseus bone fusion. 
Is it really a form of digital OA or is it a subset of 
spondyloarthropathy? It certainly does not look like sero- 
negative rheumatoid arthritis, as there is no juxtaarticular 
demineralization. 
Exclusion of asymptomatic structural OA; in actuality, 
symptoms may be transient. 2 Most persons with radio- 
graphic hand OA do not have persistent symptoms (pain on 
most days of at least 1 month). Thus, ACR criteria identify 
cases of persistent symptomatic hand OA. 
Hand OA represents a generalized disease of hand 
joints. Evidence of symmetry and clustering by row as well 
as ray (see data from Plato et al. ~ and Hochberg et aL 4 
based on analyses from Baltimore Longitudinal Study of 
Aging (BLSA), as well as data from Egger et al. s based on 
analyses of data from the Chingford Study). Generalized 
OA (GOA) requires involvement of at least three named 
joint groups; there are both nodal and non-nodal types. 
Michael Doherty discussed the genetics of nodal GOA 
in the first session (reported in his paper in this issue). 
Hand OA is a marker of OA at other sites (see data from 
BLSA, the Chingford Study, Framingham Osteoarthritis 
Study, Study of Osteoporotic Fractures, and radium 
workers). 8 
4n summary, the ACR criteria are good for symptomatic 
disease, but radiographs should be used for epidemiologic 
and genetic studies. Hand OA is a marker for GOA, 
especially when present in two or more joint groups in the 
hand. 
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Dr Marc Hochberg presented data on hand function from 
the Women's Health and Aging Study (see paper in this 
issue by Hirsch et al.). 
Clinical tools that can be used for assessing symptomatic 
hand OA in clinical research or in trials were reviewed by 
Dr Emmanuel Maheu. 
(1) Pain: visual analog scale (VAS) or Likert scale is used 
to measure pain. The Ritchie index for the hand could 
be developed; standardized calibrated dolorimeter is 
either not validated or not reliable. 
(2) Function: Backman's hand function test has been 
developed but requires trained investigators, and 
specific material and is time consuming. 7 Dreiser 
and colleagues have validated a functional index 
which seems reliable, simple to use a and sensitive 
(see paper in this issue for data on sensitivity to 
change). Bellamy has developed the AUSCAN which 
is based on and modified from the previously 
validated format of the WOMAC index. It is available 
on request to the author. Finally, Duruoz has 
developed a hand index in RA which has not yet been 
validated in OA. 9 
(3) Performance: can be assessed by Backman's test 7 
and grip strength measurement. 
(4) Mobility: range of motion is often used; however, 
it is unclear whether this is clinically relevant. 
Furthermore, no data exist on the reliability of this 
measurement. 
(5) Stiffness: duration of morning stiffness; duration of 
stiffness after rest and the stiffness scale of AUSCAN 
can be used. 
(6) Inflammation: night pain, duration of morning stiff- 
ness, joint swelling, local redness or heat are often 
used regardless their clinical relevance, reliability and 
responsiveness. 
(7) Deformity: bony enlargement (yes, no); presence or 
absence of Heberden nodes; joint circumference 
using jeweller's rings (not reliable); and measurement 
of axial deviation have all been used. 
(8) Aesthetic damage: there is no tool available, but this 
domain should be assessed, since this a major 
concern for patients, especially women. 
In conclusion, Dr Maheu recommended the use of vali- 
dated tools: VAS for pain, Dreiser's index or AUSCAN for 
function, and patient global assessment. He suggested that 
consideration be given towards development of either a 
Ritchie or Doyle index for hand OA [i.e. index of pain on 
articular pressure (lateral for the interphalangeal joints, and 
vertical for trapezometacarpal joints)]; and a VAS for 
aesthetic damage. 
Dr Maheu then presented some preliminary data on a 
tool entitled 'weekly self-assessment of painful joints '1° 
(see the paper by Lequesne and Maheu in this issue) which 
asks the patient o record weekly, on a self-report diagram, 
which joint is painful and the number of days of pain. It 
represents a flow of pain for a given patient and can be 
statistically analysed by an area under the curve approach. 
Clinical relevance, feasibility, and external validity have 
been tested in a study of 54 patients with symptomatic 
hand OA (pain on VAS_>30 mm and Dreiser's index_>5). It 
takes an average of 5 min to explain the test to patients. 
Correlation between score and VAS pain ranged from 
0.44-0.52; correlation between score and Dreiser's index 
ranged from 0.44 to 0.60. This test is presently being 
modified to develop a new clinical method to better 
longitudinally assess patients with hand OA. 
Ms Christine Chaisson reviewed her data from the 
Framingham Study on the association of grip strength with 
increased risk of developing hand OA (see paper in this 
issue). Grip strength was measured in 1962-1965; radio- 
graphs were taken in 1966-1969 and 1992-1993. Joint 
groups were categorized as distal interphalangeal (DIPs), 
proximal interphalangeal (PIPs), metacarpophalangeal 
(MCPs) and thumb base (including thumb MCP) joints. The 
analysis included 746 subjects with baseline and follow-up 
X-rays, of which 453 had no prevalent hand OA at baseline. 
Grip strength at baseline was higher in men than women. 
Cumulative incidence of hand OA in the thumb base and 
MCP joints in both sexes was associated with higher grip 
strength; no association was found at the DIP joints in 
either sex, and only a weak association at PIP joints for 
men only. The mechanism is probably anatomical and 
biomechanical with increased forces across the most 
proximal joints (MCP and thumb base). 
Dr Renee-Liliane Dreiser finished validation of her func- 
tional index in 1995. 8 Ten questions are scored on a 0-3 
scale (no difficulty, slight difficulty, great difficulty and 
impossible). The exact translation in English is 'are you 
able to' rather than 'can you'. She presented new data on 
sensitivity to change from a clinical trial of 261 patients with 
hand OA. At baseline, patients had a mean (S.D.) score of 
10.4 (3.7), At completion, the mean (S.D.) change was -3.0 
(4.9) with mean standardized response (MSR) of 0.61. In 
the intention-to-treat population, the mean (s.o.) change 
was -2.8 (4.8) with an MSR of 0.58. This includes both 
active and placebo groups. The mean standardized 
response (MSR) is less than for VAS pain but greater than 
with morning stiffness and grip strength (see paper in this 
issue). 
Professor Nicholas Bellamy reviewed the development and 
validation of AUSCAN Hand Osteoarthritis Index. This is a 
self-administered questionnaire with 15 items (five pain, 
one stiffness and nine function) which is reliable, valid and 
sensitive to change (using Likert scale). He then discussed 
the data presented on clinical tools to be used for assess- 
ing hand OA patients and recommended core outcomes for 
use in studies of hand OA (Table I). 
The final general discussion that followed allowed the 
identification of points of agreement and disagreement, and 
propositions to improve our knowledge and understanding 
of hand OA, which are presented in Tables II-V. 
Table I 
Core outcomes for clinical trials in hand osteoarthritis (proposed by 
N. Bellamy) 
Pain (VAS or Likert scale) 
Functional index (AUSCAN or Dreiser's) 
Patient global assessment 
Structure (see synthesis of third session) 
Number of painful or tender joints 
Grip strength 
Pinch strength 
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Table II 
What do we agree on? 
(1) Two or more joints are required to have hand OA. This 
depends on age and sex. 
(2) Generalized hand OA requires involvement of two or more • 
joint groups in the hand; the interphalangeal joints (DIPs 
and PIPs) should be considered as one joint group. 
(3) Symptoms in patients with hand OA may be transient or 
intermittent. 
(4) ACR criteria should be used to identify patients for inclusion 
in clinical studies of hand OA. / 
(5) Symptomatic hand OA is associated with physical disability 
assessed by decreased grip and pinch strength and 
difficulty performing daily activities. 
(6) Patients self-reported ifficulty with daily activities should be 
assessed with a valid and reliable measure, such as the 
Dreiser's functional index or AUSCAN OA index. 
(7) VAS or Likert scales are valid, reliable and responsive tools 
to measure pain in patients with hand OA. 
(8) Chris Buckland-Wright states that IP joint of the thumb is 
anatomically a DIP joint and the thumb 'MCP' is really a 
PIP joint as there is.no thumb metacarpal bone. 
Table V 
What should be done to make further progress? 
We should answer the above questions! 
(1) Study different definitions of hand OA (e.g. radiographic 
and clinical) and their relationship with OA at other sites. 
(2) Conduct long-term longitudinal cohort studies of patients 
with hand OA with standardized measures to assess 
outcomes and factors associated with poor outcomes. 
(3) Assess the utility in clinical studies of clinical 
assessment tools for hand OA: 
• AUSCAN OA index; 
• Dreiser functional index (it appears to be based on 
dominant hand); 
• hand diagrams; 
• number of painful and/or tender joints on examination; 
• weekly self-assessment of painful joints (proposed by 
E. Maheu). 
(4) Develop and validate an index to assess aesthetic 
changes as a consequence of hand OA. 
(5) Develop a definition of response based on a 
combination of the above clinical assessments to be 
used in future clinical trials of patients with hand OA. 
Table III 
What do we disagree about? 
(1) Definition of generalized OA. The discussion led to the 
conclusion that hand OA should not be considered as only 
one group; rather the IP joints (DIPs and PIPs) should be 
considered as one group and the first carpometacarpal 
joints (CMC1) should be considered as a separate group. 
(2) Erosive OA is not a subset of hand OA. Rather, erosive OA 
is on a continuum with hand OA. 
Table IV 
What we don't know? 
(1) Is it of value to separate subsets of patients with thumb 
base disease from those with interphalangeal joint 
involvement? It depends on the question of the study. Dr 
Buckland-Wright stated that the hand is an integrated organ 
and should be considered as a whole. However, 
epidemiologic studies suggest that IP joints and CMC joints 
may have different risk factors (see Ms Chaisson's work on 
grip strength in the Framingham OA study). 
(2) Is it of value to measure grip and/or pinch strength, as 
outcome measures in clinical trials in hand OA (i.e. are they 
valid, reliable and responsive to change)? 
(3) Which is more responsive to change in clinical trials: 
Dreiser's functional index or AUSCAN OA index? 
(4) What is the relationship between structural changes, pain, 
and loss of function and reduced health-related quality of 
life in patients with hand OA (cross-sectional and 
longitudinal)? 
(5) What is the relationship between the number and severity 
of affected joints and loss of function: is it linear, 
exponential or is there a threshold level? 
(6) Is it of value to measure the number of painful/tender joints 
as an outcome measure in clinical trials of hand OA (e.g. 
modified Doyle index)? 
(7) What is the role of inflammation in the pathophysiology of 
pain in hand OA? 
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